MARKET

CRDF

CRDF

Cardiff Oncology Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.03
-1.01
-10.04%
Opening 14:52 05/06 EDT
OPEN
9.86
PREV CLOSE
10.04
HIGH
10.04
LOW
8.95
VOLUME
441.01K
TURNOVER
--
52 WEEK HIGH
25.50
52 WEEK LOW
0.8250
MARKET CAP
339.18M
P/E (TTM)
-6.9393
1D
5D
1M
3M
1Y
5Y
Strength Seen in Cardiff Oncology (CRDF): Can Its 10.3% Jump Turn into More Strength?
Zacks.com · 10h ago
Let's Take A Look At This Weeks Top Performing Sectors 5/5
Investing in different stock sectors allows you to diversify your portfolio through targeted exposure from companies in specific segments of the economy. Utilizing sector-based investment strategies can help you capitalize on changing business cycles. 
Benzinga · 1d ago
Rising P/E: An Overlooked Way to Pick 5 Winning Stocks
Zacks.com · 04/29 10:03
America First Investment Advisors, LLC Buys Johnson & Johnson, iShares Core U.S. ...
GuruFocus News · 04/28 19:38
Let's Take A Look At This Weeks Top Performing Sectors 4/28
Using sector-based investment strategies can help you capitalize on changing business cycl
Benzinga · 04/28 13:28
10 “Strong Buy” Healthcare Stocks With Over 100% Upside Potential According to Top Analysts
TipRanks.com · 04/27 13:58
Analysts Say ‘Buy the Pullback’ in These 3 Stocks
Stock traders are known for their occasional love of aphorisms, and several come readily to mind. ‘Buy low, sell high’ and ‘don’t try to time the market’ are two that
TipRanks.com · 04/23 15:39
Rising P/E: An Overlooked Strategy to Pick Winning Stocks
Zacks.com · 04/14 10:49
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CRDF. Analyze the recent business situations of Cardiff Oncology Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CRDF stock price target is 26.25 with a high estimate of 30.00 and a low estimate of 23.00.
EPS
Institutional Holdings
Institutions: 99
Institutional Holdings: 27.15M
% Owned: 72.29%
Shares Outstanding: 37.55M
TypeInstitutionsShares
Increased
17
4.36M
New
35
8.17M
Decreased
20
1.26M
Sold Out
20
2.87M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.40%
Pharmaceuticals & Medical Research
-1.00%
Key Executives
Chairman/Director
Rodney Markin
Chief Executive Officer/Director
Mark Erlander
Director
Thomas Adams
Independent Director
James Armitage
Independent Director
Paul Billings
Independent Director
John Brancaccio
Independent Director
Gary Jacob
Independent Director
Gary Pace
Independent Director
Lale White
No Data
  • All
  • Financials
  • Insiders
More
About CRDF
Cardiff Oncology Inc., formerly Trovagene, Inc., is a clinical-stage biotechnology company. The Company is focused on developing treatment options for cancer patients. It is developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. Its clinical programs include KRAS-Mutated Metastatic Colorectal Cancer (mCRC), Resistant Metastatic Castration-Resistant Prostate Cancer (mCRPC) and relapsed or refractory Acute Myeloid Leukemia (AML). Its programs include the development of onvansertib in a Phase-I b/2 study of onvansertib in combination with FOLFIRI/Avastin in mCRC; a Phase II study of onvansertib in combination with Zytiga (abiraterone)/prednisone in Zytiga-resistant mCRPC, and a Phase-II study of onvansertib in combination with decitabine in AML.

Webull offers kinds of Cardiff Oncology Inc stock information, including NASDAQ:CRDF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRDF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CRDF stock methods without spending real money on the virtual paper trading platform.